BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17131060)

  • 1. The cold case: are rhinoviruses perfectly adapted pathogens?
    Dreschers S; Dumitru CA; Adams C; Gulbins E
    Cell Mol Life Sci; 2007 Jan; 64(2):181-91. PubMed ID: 17131060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICAM-1 induced rearrangements of capsid and genome prime rhinovirus 14 for activation and uncoating.
    Hrebík D; Füzik T; Gondová M; Šmerdová L; Adamopoulos A; Šedo O; Zdráhal Z; Plevka P
    Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33947819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human rhinovirus 3 at 3.0 A resolution.
    Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
    Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Rhinovirus Diversity and Evolution: How Strange the Change from Major to Minor.
    Lewis-Rogers N; Seger J; Adler FR
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the pathophysiology of rhinovirus upper respiratory tract infections.
    van Kempen M; Bachert C; Van Cauwenberge P
    Rhinology; 1999 Sep; 37(3):97-103. PubMed ID: 10567986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.
    Murer L; Petkidis A; Vallet T; Vignuzzi M; Greber UF
    J Virol; 2022 Jan; 96(2):e0106021. PubMed ID: 34705560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dynamics of receptor recognition by human rhinoviruses.
    Casasnovas JM
    Trends Microbiol; 2000 Jun; 8(6):251-4. PubMed ID: 10838576
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive bioinformatic identification of minor receptor group human rhinoviruses.
    Weber C; Pickl-Herk A; Khan AG; Strauss S; Carugo O; Blaas D
    FEBS Lett; 2009 Aug; 583(15):2547-51. PubMed ID: 19615999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Models of contrasting strategies of rhinovirus immune manipulation.
    Adler FR; Kim PS
    J Theor Biol; 2013 Jun; 327():1-10. PubMed ID: 23485454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in rhinovirus therapeutics.
    Charles CH; Yelmene M; Luo GX
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):331-7. PubMed ID: 15578974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of major group rhinoviruses by soluble intercellular adhesion molecule-1 (sICAM-1).
    Last-Barney K; Marlin SD; McNally EJ; Cahill C; Jeanfavre D; Faanes RB; Merluzzi VJ
    J Virol Methods; 1991 Dec; 35(3):255-64. PubMed ID: 1687741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.
    Hadfield AT; Lee Wm; Zhao R; Oliveira MA; Minor I; Rueckert RR; Rossmann MG
    Structure; 1997 Mar; 5(3):427-41. PubMed ID: 9083115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
    Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
    J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.
    Rollinger JM; Schmidtke M
    Med Res Rev; 2011 Jan; 31(1):42-92. PubMed ID: 19714577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The common cold.
    Van Cauwenberge PB; van Kempen MJ; Bachert C
    Acta Otorhinolaryngol Belg; 2000; 54(3):397-401. PubMed ID: 11082776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the kinetic on- and off-rate of single virus-cell interactions.
    Rankl C; Wildling L; Neundlinger I; Kienberger F; Gruber H; Blaas D; Hinterdorfer P
    Methods Mol Biol; 2011; 736():197-210. PubMed ID: 21660729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification and evolution of human rhinoviruses.
    Palmenberg AC; Gern JE
    Methods Mol Biol; 2015; 1221():1-10. PubMed ID: 25261302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion.
    Hoover-Litty H; Greve JM
    J Virol; 1993 Jan; 67(1):390-7. PubMed ID: 8093221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection.
    Marlin SD; Staunton DE; Springer TA; Stratowa C; Sommergruber W; Merluzzi VJ
    Nature; 1990 Mar; 344(6261):70-2. PubMed ID: 1968231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies.
    Niespodziana K; Cabauatan CR; Pazderova P; Vacal PC; Wortmann J; Keller W; Errhalt P; Valenta R
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.